Creekmur Asset Management’s abrdn Life Sciences Investors HQL Stock Holding History

Creekmur Asset Management’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$3.57K	Buy	230 +7	+3%	+$96	﹤0.01%	594
2025 Q2	$2.86K	Buy	223 +7	+3%	+$86	﹤0.01%	615
2025 Q1	$2.74K	Buy	216 +8	+4%	+$108	﹤0.01%	581
2024 Q4	$2.73K	Hold	208	–	–	﹤0.01%	559
2024 Q3	$3.14K	Hold	208	–	–	﹤0.01%	589
2024 Q2	$2.95K	Hold	208	–	–	﹤0.01%	654
2024 Q1	$2.84K	Buy	208 +8	+4%	+$111	﹤0.01%	627
2023 Q4	$2.69K	Buy	+200	New	+$2.46K	﹤0.01%	662

Other funds holding HQL

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Creekmur Asset Management's HQL Position: Q3 2025 in Review

Creekmur Asset Management increased its abrdn Life Sciences Investors (HQL) stake by 3.1% in Q3 2025, buying an estimated $96 and bringing the position to 230 shares worth $3.57K. The position accounts for ﹤0.01% of the portfolio, ranked #594.

Creekmur Asset Management first reported a position in HQL in Q4 2023 and has held it in 8 quarters since. 83 funds tracked by Wall St. Rank hold HQL as of Q3 2025.

Creekmur Asset Management held 230 shares of abrdn Life Sciences Investors worth $3.57K as of Q3 2025.
Creekmur Asset Management bought 7 abrdn Life Sciences Investors shares in Q3 2025, an estimated $96.
abrdn Life Sciences Investors made up ﹤0.01% of Creekmur Asset Management's portfolio in Q3 2025, its #594 holding.
Creekmur Asset Management first reported a position in abrdn Life Sciences Investors in Q4 2023 and has held it in 8 quarters since.
83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2025.

Based on Creekmur Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.